Hide and Seek: Brain Cancer Cells 'lose' Mutations to Evade Cancer Drugs

Published December 8, 2013

Hide and seek: Brain cancer cells 'lose' mutations to evade cancer drugs
According to the researchers, this study has huge implications for the future treatment of glioblastoma multiforme (GBM) – a brain cancer that is in desperate need of effective therapies. “It's one of the most common types of adult brain cancer and one … Read more on Fox News

Gillibrand challenges FDA OK of hydrocodone drug
The San Diego-based manufacturer, Zogenix Inc., had no immediate comment. Zogenix president Stephen Farr said last month that it had "started the development of an abuse-deterrent formulation of Zohydro ER, and we are committed to advancing the program … Read more on Newsday

BCH, Cigna try 'pay for value' to cut costs
Accountable Care Organizations are the result of a provision in the Affordable Care Act that allows the federal Medicare program to reward doctors and hospitals who save money on Medicare patient treatment. The new "pay for value" structure for the … Read more on Boulder County Business Report